Join us in this enlightening episode with Dylan Beynon, founder of Mind Bloom, as we dive deep into the transformative world of psychedelic therapy. Discover how ketamine, a legally prescribable psychedelic in the U.S., is revolutionizing mental health treatment. Dylan shares his personal journey, driven by family experiences, that led him to champion this cause. We discuss the science behind ketamine's neuroplastic effects on the brain, its potential in treating a range of mental health issues, and the distinction between therapeutic and recreational use. With over 300,000 psychedelic therapy sessions since 2019, Mind Bloom is at the forefront of this groundbreaking approach. Tune in to uncover the future of mental health treatment. Hosted on Acast. See acast.com/privacy for more information.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related